CRISPR Therapeutics AG 10-K for FY2021
CRISPR Therapeutics AG (CRSP)
10-K
2022-02-15
For: 2021-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 15, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $914.96M
- up 127154.9% from $719K a year earlier
- Net income
- $377.66M
- compared with a net loss of $348.87M a year earlier
- Diluted EPS
- $4.70
- compared with -$5.29 a year earlier